CLEC4MandSTXBP5gene variations contribute to von Willebrand factor level variation in von Willebrand disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CLEC4MandSTXBP5gene variations contribute to von Willebrand factor level variation in von Willebrand disease
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 13, Issue 6, Pages 956-966
Publisher
Wiley
Online
2015-04-01
DOI
10.1111/jth.12927
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STXBP1 promotes Weibel-Palade body exocytosis through its interaction with the Rab27A effector Slp4-a
- (2014) D. van Breevoort et al. BLOOD
- von Willebrand disease and aging: an evolving phenotype
- (2014) Y. V. Sanders et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels
- (2013) N. Rydz et al. BLOOD
- Reduced prevalence of arterial thrombosis in von Willebrand disease
- (2013) Y. V. Sanders et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies
- (2012) Paula D. James et al. AMERICAN JOURNAL OF HEMATOLOGY
- Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam Study
- (2012) M. C. VAN SCHIE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of Genetic Variation in STXBP5 and STX2 on von Willebrand Factor and Bleeding Phenotype in Type 1 von Willebrand Disease Patients
- (2012) Janine E. van Loon et al. PLoS One
- Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease
- (2012) Eva M. de Wee et al. THROMBOSIS AND HAEMOSTASIS
- Index Event Bias as an Explanation for the Paradoxes of Recurrence Risk Research
- (2011) Issa J. Dahabreh JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand disease
- (2011) J. D. ROBERTSON et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease
- (2011) Eva de Wee et al. THROMBOSIS AND HAEMOSTASIS
- Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor
- (2010) Nicholas L. Smith et al. CIRCULATION
- Effect of Genetic Variations in Syntaxin-Binding Protein-5 and Syntaxin-2 on von Willebrand Factor Concentration and Cardiovascular Risk
- (2010) Janine E. van Loon et al. Circulation-Cardiovascular Genetics
- Health-related quality of life among adult patients with moderate and severe von Willebrand disease
- (2010) E. M. DE WEE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels
- (2010) P.-E. MORANGE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor
- (2008) L. Gallinaro et al. BLOOD
- The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E
- (2008) E. N. Harris et al. GLYCOBIOLOGY
- Bleeding scores in inherited bleeding disorders: clinical or research tools?
- (2008) A. TOSETTO et al. HAEMOPHILIA
- Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease
- (2008) M. BOWMAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 Women
- (2008) Guillaume Paré et al. PLoS Genetics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started